Endurant Capital Management as of June 30, 2022
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 49 positions in its portfolio as reported in the June 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Invacare Corp Note 5.000%11/1 | 17.5 | $50M | 57M | 0.88 | |
| Qiagen Nv Shs New | 6.6 | $19M | 398k | 47.20 | |
| Boston Scientific Corporation (BSX) | 5.5 | $16M | 418k | 37.27 | |
| Avantor (AVTR) | 4.9 | $14M | 451k | 31.10 | |
| Humana (HUM) | 4.5 | $13M | 27k | 468.09 | |
| Spdr Ser Tr S&p Biotech Call Option (XBI) | 4.1 | $12M | 157k | 74.27 | |
| Icon SHS (ICLR) | 3.8 | $11M | 50k | 216.70 | |
| Cigna Corp (CI) | 3.7 | $11M | 40k | 263.52 | |
| Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY) | 3.4 | $9.8M | 26k | 377.26 | |
| Invacare Corp Note 5.000%11/1 | 3.2 | $9.2M | 10M | 0.92 | |
| Hologic (HOLX) | 3.1 | $8.8M | 128k | 69.30 | |
| Laboratory Corp Amer Hldgs Com New | 2.9 | $8.1M | 35k | 234.37 | |
| Aziyo Biologics Cl A Com Stk (ELUT) | 2.8 | $8.0M | 1.1M | 7.07 | |
| Bio Rad Labs Cl A (BIO) | 2.8 | $7.9M | 16k | 495.01 | |
| Zoetis Cl A (ZTS) | 2.5 | $7.1M | 41k | 171.90 | |
| Selecta Biosciences | 2.1 | $6.0M | 4.6M | 1.31 | |
| Seagen | 2.0 | $5.8M | 33k | 176.93 | |
| Centene Corporation (CNC) | 2.0 | $5.8M | 68k | 84.61 | |
| Baxter International (BAX) | 2.0 | $5.8M | 90k | 64.23 | |
| Si-bone (SIBN) | 2.0 | $5.7M | 430k | 13.20 | |
| McKesson Corporation (MCK) | 1.8 | $5.2M | 16k | 326.20 | |
| Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 1.3 | $3.7M | 13k | 280.30 | |
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 1.2 | $3.5M | 460k | 7.52 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 1.1 | $3.1M | 1.8M | 1.70 | |
| Ocular Therapeutix (OCUL) | 1.1 | $3.1M | 760k | 4.02 | |
| Galapagos Nv Spon Adr (GLPG) | 1.0 | $2.9M | 51k | 55.81 | |
| Insmed Com Par $.01 (INSM) | 1.0 | $2.8M | 142k | 19.72 | |
| Neurocrine Biosciences (NBIX) | 1.0 | $2.7M | 28k | 97.49 | |
| Global Blood Therapeutics In | 0.9 | $2.6M | 81k | 31.95 | |
| Tenet Healthcare Corp Com New (THC) | 0.9 | $2.5M | 47k | 52.57 | |
| Incyte Corporation (INCY) | 0.8 | $2.4M | 31k | 75.97 | |
| BioMarin Pharmaceutical (BMRN) | 0.8 | $2.2M | 26k | 82.89 | |
| Dex (DXCM) | 0.7 | $1.9M | 26k | 74.52 | |
| Sutro Biopharma (STRO) | 0.7 | $1.9M | 358k | 5.21 | |
| Fate Therapeutics (FATE) | 0.6 | $1.8M | 72k | 24.78 | |
| Arcus Biosciences Incorporated (RCUS) | 0.6 | $1.6M | 65k | 25.34 | |
| AmerisourceBergen (COR) | 0.6 | $1.6M | 12k | 141.47 | |
| Merit Medical Systems (MMSI) | 0.4 | $1.1M | 20k | 54.29 | |
| Acadia Healthcare (ACHC) | 0.4 | $1.1M | 16k | 67.64 | |
| Zimmer Holdings (ZBH) | 0.4 | $1.0M | 9.9k | 105.04 | |
| Albireo Pharma | 0.3 | $751k | 38k | 19.85 | |
| Horizon Therapeutics Pub L SHS | 0.2 | $674k | 8.5k | 79.73 | |
| Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.2 | $654k | 23k | 28.42 | |
| Axsome Therapeutics (AXSM) | 0.2 | $584k | 15k | 38.31 | |
| Adc Therapeutics Sa SHS (ADCT) | 0.2 | $469k | 59k | 7.95 | |
| Cytokinetics Com New (CYTK) | 0.2 | $453k | 12k | 39.26 | |
| Biodesix (BDSX) | 0.1 | $214k | 131k | 1.64 | |
| Praxis Precision Medicines I | 0.1 | $194k | 79k | 2.45 | |
| Immunic (IMUX) | 0.0 | $106k | 31k | 3.47 |
